Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
295
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
+2.18M
-
Total reported value, excl. options
-
$2.63B
-
Value change
-
+$166M
-
Put/Call ratio
-
0.81
-
Number of buys
-
168
-
Number of sells
-
-151
-
Price
-
$67.28
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q1 2025
383 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q1 2025.
TransMedics Group, Inc. - Common Stock (TMDX) has 295 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.25M shares), FMR LLC (5M shares), VANGUARD GROUP INC (3.57M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (3.11M shares), STATE STREET CORP (1.31M shares), FIL Ltd (1.23M shares), MACQUARIE GROUP LTD (1.12M shares), BRAIDWELL LP (855K shares), Hood River Capital Management LLC (796K shares), and GEODE CAPITAL MANAGEMENT, LLC (793K shares).
This table shows the top 295 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.